⌘K

Login Start Free

Home/Filings/4/0000899243-19-030045

4//SEC Filing

Orford Keith 4

Accession 0000899243-19-030045

CIK 0001496671other

View on SEC.gov Company Profile

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 4:01 PM ET

Size

4.9 KB

Accession

0000899243-19-030045

Insider Transaction Report

Form 4

Period: 2019-12-23

Calithera Biosciences, Inc.CALA

SR. VP, CLINICAL DEVELOPMENT

Transactions

Sale
Common Stock
2019-12-23$6.00/sh−3,021$18,126→ 11,562 total

Footnotes (2)

[F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan.
[F2]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 10, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

Entity typeother

Related Parties

1

filerCIK 0001670740

Filing Metadata

Form type: 4
Filed: Dec 25, 7:00 PM ET
Accepted: Dec 26, 4:01 PM ET
Size: 4.9 KB

View on SEC.gov